Label: MOTION SICKNESS- dimenhydrinate tablet
- NDC Code(s): 11673-198-02, 11673-198-08
- Packager: Target Corporation
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated March 12, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each tablet)
- Purpose
- Uses
-
Warnings
Ask a doctor before use if you have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- difficulty in urination due to enlargement of the prostate gland
-
Directions
- to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity
adults and children 12 years and over 1 to 2 tablets every 4-6 hours; do not exceed 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years ½ to 1 tablet every 6-8 hours; do not exceed 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years ½ tablet every 6-8 hours; do not exceed 1½ tablets in 24 hours, or as directed by a doctor
- to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity
- Other information
- Inactive ingredients
- Questions or comments?
-
Principal Display Panel
Compare to active ingredient in Dramamine® Original Formula*
Motion Sickness Relief
Dimenhydrinate 50 mg/Antiemeticup&up
• Helps prevent nausea, dizziness and vomiting
from motion sickness
• For adults and childrenActual Size
24 TabletsTAMPER EVIDENT: DO NOT USE
IF PACKAGE IS OPENED OR IF
BLISTER UNIT IS TORN,
BROKEN OR SHOWS ANY
SIGNS OF TAMPERING*This product is not manufactured or distributed by
Medtech Products Inc., owner of the registered trademark
Dramamine® Original Formula. 50844 REV0518F19808094 01 0726 R00 C-002262-01-034-0000
Distributed by Target Corporation
Minneapolis, MN 55403
TM & ©2024 Target Brands, Inc.
NDC 11673-198-08Target 44-198
-
INGREDIENTS AND APPEARANCE
MOTION SICKNESS
dimenhydrinate tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:11673-198 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DIMENHYDRINATE (UNII: JB937PER5C) (DIPHENHYDRAMINE - UNII:8GTS82S83M, 8-CHLOROTHEOPHYLLINE - UNII:GE2UA340FM) DIMENHYDRINATE 50 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) STEARIC ACID (UNII: 4ELV7Z65AP) Product Characteristics Color white Score 2 pieces Shape ROUND Size 9mm Flavor Imprint Code 44;198 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:11673-198-02 2 in 1 CARTON 12/01/1992 1 6 in 1 BLISTER PACK; Type 0: Not a Combination Product 2 NDC:11673-198-08 4 in 1 CARTON 12/01/1992 2 6 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M009 12/01/1992 Labeler - Target Corporation (006961700) Establishment Name Address ID/FEI Business Operations LNK International, Inc. 038154464 pack(11673-198) Establishment Name Address ID/FEI Business Operations LNK International, Inc. 832867837 manufacture(11673-198) , pack(11673-198) Establishment Name Address ID/FEI Business Operations LNK International, Inc. 117025878 manufacture(11673-198)